Related references
Note: Only part of the references are listed.Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Effects of Buprenorphine on Responses to Emotional Stimuli in Individuals with a Range of Mood Symptomatology
Anya K. Bershad et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [C-11]NOP-1A
Rajesh Narendran et al.
BIOLOGICAL PSYCHIATRY (2018)
mu opioid receptor, social behaviour and autism spectrum disorder: reward matters
Lucie P. Pellissier et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Prescription Opioid Use among Adults with Mental Health Disorders in the United States
Matthew A. Davis et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2017)
Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?
Abraham Madariaga-Mazon et al.
DRUG DISCOVERY TODAY (2017)
It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2017)
A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies
Anke Post et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence
Anke Post et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial
Yoram Yovell et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-D-aspartate and opioid receptors
Arya Haj-Mirzaian et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder
Karen H. Seal et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
Erica M. Richards et al.
PSYCHOPHARMACOLOGY (2016)
Antidepressant-like effects of buprenorphine in rats are strain dependent
Caroline A. Browne et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Biased agonism at kappa opioid receptors: Implication in pain and mood disorders
Shalini Dogra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
The role of early pharmacotherapy in the development of posttraumatic stress disorder symptoms after traumatic injury: an observational cohort study in consecutive patients
Joanne Mouthaan et al.
GENERAL HOSPITAL PSYCHIATRY (2015)
Delta opioid agonists: a concise update on potential therapeutic applications
J. F. Peppin et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)
Test-Retest Reproducibility of Binding Parameters in Humans with 11C-LY2795050, an Antagonist PET Radiotracer for the κ Opioid Receptor
Mika Naganawa et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice
Abdulrahman Almatroudi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder
D. T. Hsu et al.
MOLECULAR PSYCHIATRY (2015)
Association Between Placebo-Activated Neural Systems and Antidepressant Responses Neurochemistry of Placebo Effects in Major Depression
Marta Pecina et al.
JAMA PSYCHIATRY (2015)
Effects of the Mu Opioid Receptor Polymorphism (OPRM1 A118G) on Pain Regulation, Placebo Effects and Associated Personality Trait Measures
Marta Pecina et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Evaluation of Opioid Modulation in Major Depressive Disorder
Elliot Ehrich et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice
Edgardo Falcon et al.
PSYCHOPHARMACOLOGY (2015)
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches
Jeremy D. Coplan et al.
WORLD JOURNAL OF PSYCHIATRY (2015)
Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review
A. Roy et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2015)
Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults
Jordan F. Karp et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Investigational drugs for pruritus
Heike Benecke et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Active behaviours produced by antidepressants and opioids in the mouse tail suspension test
Esther Berrocoso et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Response of the μ-opioid system to social rejection and acceptance
D. T. Hsu et al.
MOLECULAR PSYCHIATRY (2013)
Endogenous opiates and behavior: 2012
Richard J. Bodnar
PEPTIDES (2013)
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs
Elaine Cristina Gavioli et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Morphine prevents the development of stress-enhanced fear learning
Jennifer L. Szczytkowski-Thomson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR
Jinsong Peng et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
The pain of social disconnection: examining the shared neural underpinnings of physical and social pain
Naomi I. Eisenberger
NATURE REVIEWS NEUROSCIENCE (2012)
Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats
Elena Chartoff et al.
NEUROPHARMACOLOGY (2012)
Kappa Opioid Receptor Signaling in the Basolateral Amygdala Regulates Conditioned Fear and Anxiety in Rats
Allison T. Knoll et al.
BIOLOGICAL PSYCHIATRY (2011)
The Therapeutic Potential of kappa-Opioids for Treatment of Pain and Addiction
Charles Chavkin
NEUROPSYCHOPHARMACOLOGY (2011)
Social rejection shares somatosensory representations with physical pain
Ethan Kross et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An Opioid Deficit in Borderline Personality Disorder: Self-Cutting, Substance Abuse, and Social Dysfunction
Antonia S. New et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
The Interpersonal Dimension of Borderline Personality Disorder: Toward a Neuropeptide Model
Barbara Stanley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Dysregulation of Regional Endogenous Opioid Function in Borderline Personality Disorder
Alan R. Prossin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters
Barbara Stanley et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats
Gregory V. Carr et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder
Troy Lisa Holbrook et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory
Massimiliano Di Filippo et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
A Study of the Protective Function of Acute Morphine Administration on Subsequent Posttraumatic Stress Disorder
Richard A. Bryant et al.
BIOLOGICAL PSYCHIATRY (2009)
Opiates as Antidepressants
Esther Berrocoso et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Measurement of central μ-opioid receptor binding in vivo with PET and [11C] carfentanil: a test-retest study in healthy subjects
Jussi Hirvonen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
The role of beta-endorphin in the pathophysiology of major depression
K. M. Hegadoren et al.
NEUROPEPTIDES (2009)
Reward Processing by the Opioid System in the Brain
Julie Le Merrer et al.
PHYSIOLOGICAL REVIEWS (2009)
Kappa-opioid ligands in the study and treatment of mood disorders
William A. Carlezon et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection
Baldwin M. Way et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy
Peter W. Nyhuis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Roles of opioid receptor subtypes on the antinociceptive effect of intrathecal sildenafil in the formalin test of rats
Myung Ha Yoon et al.
NEUROSCIENCE LETTERS (2008)
Differences in δ- and μ-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects
Elise M. Weerts et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Psychotherapeutic benefits of opioid agonist therapy
Peter L. Tenore
JOURNAL OF ADDICTIVE DISEASES (2008)
Risk for recurrence in depression
Stephanie L. Burcusa et al.
CLINICAL PSYCHOLOGY REVIEW (2007)
Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5, 9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082)
Mario D. Aceto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]:: In vivo studies
Anna Rizzi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women
Susan E. Kennedy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Worsening of obsessive-compulsive symptoms under methadone tapering
Yasser Khazaal et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
The mesolimbic dopamine reward circuit in depression
Eric J. Nestler et al.
BIOLOGICAL PSYCHIATRY (2006)
Maintenance treatment of major depression in old age
CF Reynolds et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands
EC Gavioli et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats
WA Carlezon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress
RY Chong et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system
Jay P. McLaughlin et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Opening the DOR on antidepressant effects
Emily M. Jutkiewicz
MOLECULAR INTERVENTIONS (2006)
Opioid Ligands with mixed mu/delta opioid receptor interactions: An emerging approach to novel analgesics
S Ananthan
AAPS JOURNAL (2006)
Hedonic hot spot in nucleus accumbens shell:: Where do μ-opioids cause increased hedonic impact of sweetness?
S Peciña et al.
JOURNAL OF NEUROSCIENCE (2005)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Placebo effects mediated by endogenous opioid activity on μ-opioid receptors
JK Zubieta et al.
JOURNAL OF NEUROSCIENCE (2005)
Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test
ADE Zomkowski et al.
NEUROSCIENCE LETTERS (2005)
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder
LM Koran et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats
MS Todtenkopf et al.
PSYCHOPHARMACOLOGY (2004)
The δ-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats
MM Torregrossa et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect
R Ciccocioppo et al.
PHYSIOLOGY & BEHAVIOR (2004)
Alcoholism: genes and mechanisms
G Oroszi et al.
PHARMACOGENOMICS (2004)
Obsessive-compulsive symptoms precipitated by methadone tapering
Y Khazaal et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Peripherally restricted opioid agonists as novel analgesic agents
DL DeHaven-Hudkins et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test
EC Gavioli et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats
SD Mague et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission
JK Zubieta et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats
MO Rojas-Corrales et al.
LIFE SCIENCES (2002)
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test
JP Redrobe et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2002)
Synaptic plasticity and mood disorders
RS Duman
MOLECULAR PSYCHIATRY (2002)
Placebo and opioid analgesia - Imaging a shared neuronal network
P Petrovic et al.
SCIENCE (2002)
Progesterone blockade of estrogen activation of μ-opioid receptors regulates reproductive behavior
K Sinchak et al.
JOURNAL OF NEUROSCIENCE (2001)
Depression - emerging insights from neurobiology
VA Vaidya et al.
BRITISH MEDICAL BULLETIN (2001)
Mice deficient for δ- and γ-opioid receptors exhibit opposing alterations of emotional responses
D Filliol et al.
NATURE GENETICS (2000)
Share Paper
